PE20080845A1 - METHOD FOR MANUFACTURING TABLETS CONTAINING PHARMACOLOGICALLY ACTIVE AGENTS - Google Patents
METHOD FOR MANUFACTURING TABLETS CONTAINING PHARMACOLOGICALLY ACTIVE AGENTSInfo
- Publication number
- PE20080845A1 PE20080845A1 PE2007001268A PE2007001268A PE20080845A1 PE 20080845 A1 PE20080845 A1 PE 20080845A1 PE 2007001268 A PE2007001268 A PE 2007001268A PE 2007001268 A PE2007001268 A PE 2007001268A PE 20080845 A1 PE20080845 A1 PE 20080845A1
- Authority
- PE
- Peru
- Prior art keywords
- active agents
- pharmacologically active
- tablets containing
- containing pharmacologically
- manufacturing tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONSTA DE UN LUBRICANTE EXTERNO TAL COMO ESTEARATO DE MAGNESIO O CALCIO, FUMARATO DE SODIO,LAURIL-SULFATO DE SODIO, ENTRE OTROS, PARA LA COMPACTACION DE UNA MEZCLA QUE CONTIENE: a) UN PRINCIPIO ACTIVO TAL COMO PROTEINA, POLIPEPTIDO, HORMONA, POLISACARIDO, CARBOHIDRATO, LIPIDO, O UNA COMBINACION DE LOS MISMOS; b) UN AGENTE DE SUMINISTRO, COMO, ACIDO N-(5-CLORO-SALICILOIL)-8-AMINO-CAPRILICO (5-CNAC), ACIDO N-(10-[2-HIDROXI-BENZOIL]-AMINO)-DECANOICO (SNAD), ACIDO N-(8-[2-HIDROXI-BENZOIL]-AMINO)-CAPRILICO (SNAC), O UNA COMBINACION DE LOS MISMOS. DICHA COMPOSICION HACE REFERENCIA A UNA MEJORA EN LAS PROPIEDADES FISICAS DE LA TABLETA TALES COMO, DUREZA, TIEMPO DE DESINTEGRACION Y DISOLUCIONIT REFERS TO A PHARMACEUTICAL COMPOSITION THAT CONSISTS OF AN EXTERNAL LUBRICANT SUCH AS MAGNESIUM OR CALCIUM STEARATE, SODIUM FUMARATE, SODIUM LAURYL-SULPHATE, AMONG OTHERS, FOR THE COMPACTION OF A MIXTURE THAT CONTAINS: a) AN ACTIVE PRINCIPLE AS PROTEIN: a) , POLYPEPTIDE, HORMONE, POLYSACCHARIDE, CARBOHYDRATE, LIPID, OR A COMBINATION OF THEM; ( SNAD), N- (8- [2-HYDROXY-BENZOYL] -AMINE) -CAPRYLIC ACID (SNAC), OR A COMBINATION OF THEM. SAID COMPOSITION REFERS TO AN IMPROVEMENT IN THE PHYSICAL PROPERTIES OF THE TABLET SUCH AS HARDNESS, DISINTEGRATION TIME AND DISSOLUTION
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82659706P | 2006-09-22 | 2006-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080845A1 true PE20080845A1 (en) | 2008-08-13 |
Family
ID=39227036
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007001268A PE20080845A1 (en) | 2006-09-22 | 2007-09-20 | METHOD FOR MANUFACTURING TABLETS CONTAINING PHARMACOLOGICALLY ACTIVE AGENTS |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR062925A1 (en) |
CL (1) | CL2007002724A1 (en) |
PE (1) | PE20080845A1 (en) |
TW (1) | TW200820993A (en) |
WO (1) | WO2008039351A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI3326620T1 (en) | 2010-12-16 | 2020-07-31 | Novo Nordisk A/S | Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2- hydroxybenzoyl)amino)caprylic acid |
JP6022538B2 (en) | 2011-04-12 | 2016-11-09 | ノヴォ ノルディスク アー/エス | Double acylated GLP-1 derivative |
PT2827845T (en) | 2012-03-22 | 2019-03-29 | Novo Nordisk As | Compositions comprising a delivery agent and preparation thereof |
EP4324475A1 (en) | 2012-03-22 | 2024-02-21 | Novo Nordisk A/S | Compositions of glp-1 peptides and preparation thereof |
CN104203221A (en) | 2012-03-22 | 2014-12-10 | 诺和诺德A/S(股份有限公司) | Compositions comprising a delivery agent and preparation thereof |
US9993430B2 (en) | 2012-06-20 | 2018-06-12 | Novo Nordisk A/S | Tablet formulation comprising semaglutide and a delivery agent |
MX2020007598A (en) | 2018-02-02 | 2020-09-03 | Novo Nordisk As | Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4568426B2 (en) * | 1998-04-08 | 2010-10-27 | 協和発酵キリン株式会社 | Tablet manufacturing method and tablet |
AU2004255458B2 (en) * | 2003-07-11 | 2007-09-13 | Emisphere Technologies, Inc. | Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
-
2007
- 2007-09-20 PE PE2007001268A patent/PE20080845A1/en not_active Application Discontinuation
- 2007-09-20 AR ARP070104166A patent/AR062925A1/en unknown
- 2007-09-20 WO PCT/US2007/020406 patent/WO2008039351A2/en active Application Filing
- 2007-09-21 CL CL200702724A patent/CL2007002724A1/en unknown
- 2007-09-21 TW TW096135632A patent/TW200820993A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008039351A2 (en) | 2008-04-03 |
CL2007002724A1 (en) | 2008-05-16 |
WO2008039351A3 (en) | 2008-06-19 |
TW200820993A (en) | 2008-05-16 |
AR062925A1 (en) | 2008-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20080845A1 (en) | METHOD FOR MANUFACTURING TABLETS CONTAINING PHARMACOLOGICALLY ACTIVE AGENTS | |
CO6160317A2 (en) | NON-HANDLING PHARMACEUTICAL DOSAGE FORMS THAT INCLUDE AN OPIOID ANALGESIC | |
AR037490A1 (en) | SOLID PHARMACEUTICAL COMPOSITIONS, PROCESS FOR PREPARATION, KIT FOR THE TREATMENT OF OBESITY AND USE OF SUCH COMPOSITIONS IN THE DEVELOPMENT OF MEDICINES | |
EA200801926A1 (en) | TABLETS OF PARACETAMOL WITH FAST DELIVERY | |
AR027391A1 (en) | BOTULIN TOXIN PHARMACEUTICAL COMPOSITIONS | |
UY30535A1 (en) | COMPOSITION UNDERSTANDING ANTIRRETROVIRAL PHARMACOS AND AT LEAST AN INSOLUBLE WATER POLYMER, PREPARATION PROCESS AND APPLICATIONS. | |
PE20061017A1 (en) | PHARMACEUTICAL FORMULATION BY DIRECT COMPRESSION OF A DIPEPTIDIL-PEPTIDASE IV INHIBITOR AND PROCESS | |
MX2009003030A (en) | Galenic form for the trans-mucosal delivery of active ingredients. | |
ECSP088490A (en) | ORAL PHARMACEUTICAL FORM THAT CONTAINS AS ACTIVE PRINCIPLES A PROTON PUMP INHIBITOR TOGETHER WITH ACETILSALICYL ACID | |
PA8559501A1 (en) | PHARMACEUTICAL FORMULATIONS OF 5,7,14-TRIAZATETRACICLO [10.3.1.02,11.04,9] -HEXADECA-2 (11), 3,5,7,9-PENTAENO | |
ATE493973T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING IRBESARTAN | |
AR057946A1 (en) | FORMULATION OF SUSTAINED RELEASE ZONISAMIDE | |
CO6280475A2 (en) | METHOD TO TREAT THE DEFICIENCY OF VITAMIN B12 | |
CL2007003356A1 (en) | COMPOUNDS DERIVED FROM BENZOPIRAZOLES; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND ANOTHER ACTIVE AGENT; AND ITS USE FOR THE TREATMENT OF ASTHMA, INFLAMMATION, AMONG OTHER DISEASES. | |
CO6460753A2 (en) | PROCEDURE AND COMPOSITION TO IMPROVE THE ABSORPTION OF THERAPEUTIC AGENTS | |
CL2004000899A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING TELMISARTAN SODIUM SALT AND A DIURETIC AGENT AND PREPARATION PROCEDURE. | |
AR063538A1 (en) | TREATMENT OF PARKINSON'S DISEASE | |
DK1608346T3 (en) | Drug delivery compositions of alpha-hydroxy acid ester and methods of use thereof | |
AR061790A1 (en) | SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, FORMULATIONS OF IMMEDIATE RELEASE TABLETS OF A THROMBIN RECEIVER ANTAGONIST, AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT | |
PE20230819A1 (en) | COMPOSITIONS AND USES OF GLP-1 | |
AR061166A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF PHENYLPHERINE | |
ECSP044961A (en) | ACID N- (5-CHLOROSALICILOIL) -8-AMINOCAPRILICO AS AN ORAL SUPPLY AGENT FOR PARTIROID HORMONE FRAGMENTS | |
AR046036A1 (en) | RISEDRONATE COMPOSITIONS AND METHODS FOR USE | |
AR048672A1 (en) | DISINTEGRATION TABLETS THAT INCLUDE LICARBAZEPINA | |
AR036085A1 (en) | DOSAGE FORMS AND PROCEDURE FOR MANUFACTURING |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |